Patten & Patten’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-480
| Closed | -$304K | – | 332 |
|
|
2025
Q1 | $304K | Buy |
480
+14
| +3% | +$8.88K | 0.02% | 266 |
|
|
2024
Q4 | $332K | Sell |
466
-6
| -1% | -$4.27K | 0.02% | 253 |
|
|
2024
Q3 | $496K | Hold |
472
| – | – | 0.03% | 218 |
|
|
2024
Q2 | $496K | Hold |
472
| – | – | 0.03% | 216 |
|
|
2024
Q1 | $454K | Buy |
472
+6
| +1% | +$5.78K | 0.03% | 224 |
|
|
2023
Q4 | $409K | Hold |
466
| – | – | 0.03% | 215 |
|
|
2023
Q3 | $383K | Hold |
466
| – | – | 0.03% | 210 |
|
|
2023
Q2 | $335K | Hold |
466
| – | – | 0.03% | 225 |
|
|
2023
Q1 | $383K | Buy |
466
+6
| +1% | +$4.93K | 0.03% | 207 |
|
|
2022
Q4 | $332K | Hold |
460
| – | – | 0.03% | 217 |
|
|
2022
Q3 | $317K | Sell |
460
-5
| -1% | -$3.45K | 0.03% | 221 |
|
|
2022
Q2 | $275K | Hold |
465
| – | – | 0.02% | 239 |
|
|
2022
Q1 | $325K | Hold |
465
| – | – | 0.02% | 238 |
|
|
2021
Q4 | $294K | Hold |
465
| – | – | 0.02% | 244 |
|
|
2021
Q3 | $281K | Hold |
465
| – | – | 0.02% | 245 |
|
|
2021
Q2 | $260K | Hold |
465
| – | – | 0.02% | 253 |
|
|
2021
Q1 | $220K | Hold |
465
| – | – | 0.02% | 259 |
|
|
2020
Q4 | $225K | Hold |
465
| – | – | 0.02% | 240 |
|
|
2020
Q3 | $260K | Hold |
465
| – | – | 0.03% | 217 |
|
|
2020
Q2 | $290K | Hold |
465
| – | – | 0.03% | 205 |
|
|
2020
Q1 | $227K | Buy |
+465
| New | +$227K | 0.03% | 211 |
|